Longboard pharmaceuticals to present at two upcoming investor conferences

San diego, aug. 31, 2021 (globe newswire) -- longboard pharmaceuticals, inc. (nasdaq: lbph), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that kevin r. lind, longboard's president & chief executive officer, will present virtually in a fireside chat format at two upcoming investor conferences: citi's 16th annual biopharma virtual conference and h.c. wainwright's 23rd annual global investment conference.
LBPH Ratings Summary
LBPH Quant Ranking